This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Source-linked LIMA1 Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-LIMA1 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~85.2 kDa | |
| Gel | 8–10% (standard starting point) | |
| Positive control | Appendix (IHC candidate; verify WB) +4 more | |
| Negative control | Caudate (IHC candidate; verify WB) |
| PTM | Phosphorylated + Acetylated | |
| Caveat | Phosphorylation-state controls | |
| Gene-set association | MSigDB Hallmark membership | |
| Isoform | 5 isoform(s) |
The A05231 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | human colon tissue lysate (catalog A05231) |
| Gel % | 8–10% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Standard semi-dry transfer; verify efficiency (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | A05231 · (A) 0.5 and (B) 1 μg/ml (catalog A05231) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
LIMA1 has a predicted mass of 85.2 kDa; isoforms could affect band patterns, but no empirical migration is supplied.
| Band near 85.2 kDa | Consistent with the predicted LIMA1 mass; confirm identity with controls |
| Several bands at different positions | Could reflect the five annotated isoforms; their migration is unverified |
| Close doublet | Could reflect isoforms or phosphorylation; neither pattern is established |
| Band enriched in a cytoskeletal fraction | Consistent with LIMA1's cytoskeletal localization |
| UniProt predicted mass | Provides an 85.2 kDa reference, not a measured band position |
| Beta and Alpha isoforms | May differ in apparent size; individual masses are unavailable |
| Isoform 3 | May differ in apparent size; its mass is unavailable |
| Isoforms 4 and 5 | May differ in apparent size; individual masses are unavailable |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | Cytoskeleton-associated LIMA1 may be poorly recovered during extraction | Check insoluble fractions and compare extraction conditions |
| Band higher than expected | An isoform or altered migration is possible; the cause is unestablished | Compare antibody reagents and use LIMA1 depletion to test identity |
| Band lower than expected | An isoform is possible; no isoform mass is supplied | Confirm identity with LIMA1 depletion and an antibody to another epitope |
| Multiple bands | Five isoforms are annotated, but their band positions are unknown | Compare isoform expression and test which bands disappear after LIMA1 depletion |
| Weak or no signal | Extraction may underrecover cytoskeleton-associated LIMA1 | Check fraction recovery and include a validated positive lysate |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Appendix | endocrine cells | High | Protein (IHC) | HPA → |
| Breast | glandular cells | High | Protein (IHC) | HPA → |
| Cervix | glandular cells | High | Protein (IHC) | HPA → |
| Colon | endocrine cells | High | Protein (IHC) | HPA → |
| Duodenum | endocrine cells | High | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Caudate | glial cells | Not detected | Protein (IHC) | HPA → |
| Cerebral cortex | endothelial cells | Not detected | Protein (IHC) | HPA → |
| Heart muscle | cardiomyocytes | Not detected | Protein (IHC) | HPA → |
| Hippocampus | glial cells | Not detected | Protein (IHC) | HPA → |
| Liver | cholangiocytes | Not detected | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for LIMA1, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
Both listed anti-LIMA1 antibodies are reported as human-reactive and have Western blot images. A05231 was tested on human colon tissue lysate; A05231-1 was tested on four human cell lines, with reported bands near 85 and 100 kDa. Evidence is limited to these reported samples.
Which to pick: Choose A05231 for a human colon tissue lysate precedent, or A05231-1 for a human cell lysate precedent (HeLa, HepG2, 293T, or T-47D). Both have WB images; the reported sample and conditions are the useful distinction.